Literature DB >> 28888073

Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.

Stephen D Ginsberg1,2,3,4, Michael H Malek-Ahmadi5, Melissa J Alldred1,2, Shaoli Che1,2, Irina Elarova1, Yinghua Chen5, Freddy Jeanneteau6,7,8, Thorsten M Kranz2,9, Moses V Chao2,9, Scott E Counts10,11,12,13, Elliott J Mufson14.   

Abstract

Hippocampal CA1 pyramidal neurons, a major component of the medial temporal lobe memory circuit, are selectively vulnerable during the progression of Alzheimer's disease (AD). The cellular mechanism(s) underlying degeneration of these neurons and the relationship to cognitive performance remains largely undefined. Here, we profiled neurotrophin and neurotrophin receptor gene expression within microdissected CA1 neurons along with regional hippocampal dissections from subjects who died with a clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI), or AD using laser capture microdissection (LCM), custom-designed microarray analysis, and qPCR of CA1 subregional dissections. Gene expression levels were correlated with cognitive test scores and AD neuropathology criteria. We found a significant downregulation of several neurotrophin genes (e.g., Gdnf, Ngfb, and Ntf4) in CA1 pyramidal neurons in MCI compared to NCI and AD subjects. In addition, the neurotrophin receptor transcripts TrkB and TrkC were decreased in MCI and AD compared to NCI. Regional hippocampal dissections also revealed select neurotrophic gene dysfunction providing evidence for vulnerability within the hippocampus proper during the progression of dementia. Downregulation of several neurotrophins of the NGF family and cognate neurotrophin receptor (TrkA, TrkB, and TrkC) genes correlated with antemortem cognitive measures including the Mini-Mental State Exam (MMSE), a composite global cognitive score (GCS), and Episodic, Semantic, and Working Memory, Perceptual Speed, and Visuospatial domains. Significant correlations were found between select neurotrophic expression downregulation and neuritic plaques (NPs) and neurofibrillary tangles (NFTs), but not diffuse plaques (DPs). These data suggest that dysfunction of neurotrophin signaling complexes have profound negative sequelae within vulnerable hippocampal cell types, which play a role in mnemonic and executive dysfunction during the progression of AD.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Trk receptors; brain-derived neurotrophic factor; microarray; neuritic plaques; neurofibrillary tangles

Mesh:

Substances:

Year:  2017        PMID: 28888073      PMCID: PMC5844851          DOI: 10.1002/hipo.22802

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  95 in total

1.  Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function.

Authors:  T R Stoub; E J Rogalski; S Leurgans; D A Bennett; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2008-09-21       Impact factor: 4.673

Review 2.  Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.

Authors:  Akira Yoshii; Martha Constantine-Paton
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

3.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

Review 4.  Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.

Authors:  Stéphane Epelbaum; Rémy Genthon; Enrica Cavedo; Marie Odile Habert; Foudil Lamari; Geoffroy Gagliardi; Simone Lista; Marc Teichmann; Hovagim Bakardjian; Harald Hampel; Bruno Dubois
Journal:  Alzheimers Dement       Date:  2017-02-07       Impact factor: 21.566

Review 5.  Neurotrophin signalling: novel insights into mechanisms and pathophysiology.

Authors:  Mariela Mitre; Abigail Mariga; Moses V Chao
Journal:  Clin Sci (Lond)       Date:  2017-01-01       Impact factor: 6.124

6.  Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.

Authors:  E J Mufson; S Y Ma; E J Cochran; D A Bennett; L A Beckett; S Jaffar; H U Saragovi; J H Kordower
Journal:  J Comp Neurol       Date:  2000-11-06       Impact factor: 3.215

7.  Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

Authors:  R M Holsinger; J Schnarr; P Henry; V T Castelo; M Fahnestock
Journal:  Brain Res Mol Brain Res       Date:  2000-03-29

Review 8.  BDNF mediates adaptive brain and body responses to energetic challenges.

Authors:  Krisztina Marosi; Mark P Mattson
Journal:  Trends Endocrinol Metab       Date:  2013-12-19       Impact factor: 12.015

Review 9.  Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms.

Authors:  Frank M Longo; Tao Yang; Juliet K Knowles; Youmei Xie; Laura A Moore; Stephen M Massa
Journal:  Curr Alzheimer Res       Date:  2007-12       Impact factor: 3.498

10.  The neurotrophins and their role in Alzheimer's disease.

Authors:  Shelley J Allen; Judy J Watson; David Dawbarn
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

View more
  23 in total

1.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

2.  Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Bin He; Sarah M Ward; Angela L Guillozet-Bongaarts; Nicholas M Kanaan; Elliott J Mufson; Scott E Counts
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

3.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

4.  Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.

Authors:  Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson
Journal:  Acta Neuropathol       Date:  2019-02-07       Impact factor: 17.088

5.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

6.  Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Authors:  Melissa J Alldred; Helen M Chao; Sang Han Lee; Judah Beilin; Brian E Powers; Eva Petkova; Barbara J Strupp; Stephen D Ginsberg
Journal:  FASEB J       Date:  2019-06-10       Impact factor: 5.191

Review 7.  Selective vulnerability in neurodegenerative diseases.

Authors:  Hongjun Fu; John Hardy; Karen E Duff
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

Review 8.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

9.  Circular RNA Cwc27 contributes to Alzheimer's disease pathogenesis by repressing Pur-α activity.

Authors:  Chenghuan Song; Yongfang Zhang; Wanying Huang; Jiyun Shi; Qiang Huang; Minjie Jiang; Yu Qiu; Tao Wang; Hongzhuan Chen; Hao Wang
Journal:  Cell Death Differ       Date:  2021-09-09       Impact factor: 12.067

10.  Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.

Authors:  Zhourui Wu; Chun Chen; Seong Su Kang; Xia Liu; Xiaohuan Gu; Shan Ping Yu; C Dirk Keene; Liming Cheng; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.